If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGoodwin Regulatory News (GDWN)

Share Price Information for Goodwin (GDWN)

Share Price is delayed by 15 minutes
Get Live Data
17,700.00    60.00 (0.34%)
Bid:
17,660.00
Ask:
17,800.00
Spread: 140.00 (0.793%)
Market Cap: £1.35b
GDWN Live PriceLast checked at - London Stock Exchange

Intraday Goodwin Share Chart

March 2025 Trading Update

19 Mar 2025 08:00

RNS Number : 2754B
Goodwin PLC
19 March 2025
 

GOODWIN PLC

MARCH 2025 TRADING UPDATE

 

We are pleased to report that as of the end of February, the Group's forward order book has reached a new record of £300 million. This milestone reflects the strength of our long-term established contracts and the robustness of our business activities. As a result, we remain on track to deliver second-half profits comparable to those of the first half of the year.

 

One of the recent contributors to this success has been Noreva, our specialised nozzle check valve company based in Germany. Noreva has secured the largest order in its history-a $15 million contract to supply valves for an LNG project. This contract, to be fulfilled over the next two years, positions us well to benefit from the expected release of further LNG projects, in light of the growing global demand for LNG. 

 

The vertical integration within our Group continues to provide a substantial competitive advantage. A significant proportion of the castings for Noreva's major order will be sourced from Goodwin Steel Castings (GSC), our own foundry. Even though we are now casting at a rate of 10 Self Shielded Boxes (SSBs) per month for the nuclear decommissioning market, as well as continuing to cast components for the military contracts that GSC has won, all with multi-year delivery profiles and high likelihood of repeat orders, the foundry still has capacity to take on additional contracts. This puts us in an excellent position to continue to contribute to national strategic defence procurements in both the UK and USA.

 

Looking ahead, the Mechanical Division is poised for further success. While the majority of orders received this year will start to deliver financial returns in the next fiscal year, we are confident that this momentum will continue to build. Our significant investment over the past decade has equipped the Mechanical Division with the necessary facilities, size, and capability to handle increasing workloads across all areas. Our investment into the Goodwin Engineering Training Centre has also supported this growth by successfully operating for over 13 years and training over 300 apprentices to date. It is these individuals who now form part of the Group's highly skilled workforce that is required to sustain our expansion.

 

Meanwhile, our Refractory Division continues to grow and perform well. The investment casting markets, particularly in the jewellery sectors are expanding at an impressive rate, exceeding 10% growth in certain regions. As a global market leader, we are benefiting directly from this trend, with our powder companies in China, India and Thailand achieving record in-month results compared to previous years.

 

Capital expenditure across the Group has decreased significantly as expected. The primary ongoing project, which is non customer funded, is the construction of a new 1,200 m² building at Noreva. Over the next few months, once the equipment has been delivered and installed, this facility will house a CNC press operation converting Duvelco polyimide resin powder into precision pressed parts. With the reduced capital expenditure and our improved profitability, we have successfully reduced Group net debt by a further £10 million since the half-year mark.

 

Finally, with respect to dividend payments, we re-confirm that the second and final instalment of 66.5p per share for the year ending 30th April 2024, approved at our last Annual General Meeting on 2nd October 2024, will be paid on 11th April 2025 to shareholders registered on 21st March 2025.

 

The Board is delighted with the Group's performance and the strategic positioning we have achieved. With our record order book, expanding capabilities, and strong financial foundation, we are well-placed to sustain our success and drive further growth in profitability.

 

T.J.W. Goodwin

Chairman

 

END LEI: 213800N4T1NMSJ57B322

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGRGDXLXBDGUC
Date   Source Headline
10th Feb 20164:36 pmRNSPrice Monitoring Extension
18th Dec 20159:00 amRNSHalf Yearly Report
22nd Oct 20155:39 pmRNSDirector/PDMR Shareholding
7th Oct 20154:40 pmRNSResult of AGM
10th Sep 20154:21 pmRNSInterim Management Statement
6th Aug 20154:43 pmRNSAnnual Financial Report
24th Jul 20159:00 amRNSFinal Results
1st Jun 20155:08 pmRNSResignation of Director
7th May 20154:42 pmRNSDirector/PDMR Shareholding
17th Apr 20153:00 pmRNSDirector/PDMR Shareholding
16th Apr 20157:00 amRNSDirectorate Change
13th Mar 20159:30 amRNSInterim Management Statement
18th Dec 20149:00 amRNSHalf Yearly Report
20th Oct 201410:09 amRNSDirector/PDMR Shareholding
8th Oct 20145:14 pmRNSResult of AGM
10th Sep 20149:57 amRNSInterim Management Statement
1st Aug 20144:57 pmRNSAnnual Financial Report
25th Jul 20149:00 amRNSFinal Results
22nd May 20144:06 pmRNSDirector/PDMR Shareholding
25th Apr 201411:04 amRNSDirector/PDMR Shareholding
7th Mar 20149:00 amRNSInterim Management Statement
19th Dec 20139:37 amRNSHalf Yearly Report
18th Dec 20134:40 pmRNSSecond Price Monitoring Extn
18th Dec 20134:35 pmRNSPrice Monitoring Extension
17th Oct 20137:00 amRNSDirector/PDMR Shareholding
10th Oct 20137:00 amRNSAGM Statement
30th Sep 20134:40 pmRNSSecond Price Monitoring Extn
30th Sep 20134:35 pmRNSPrice Monitoring Extension
10th Sep 20139:00 amRNSInterim Management Statement
2nd Aug 201310:42 amRNSPosting of the Directors' Report and Accounts
26th Jul 20139:00 amRNSPreliminary Results
20th May 20134:40 pmRNSSecond Price Monitoring Extn
20th May 20134:35 pmRNSPrice Monitoring Extension
10th May 20134:40 pmRNSSecond Price Monitoring Extn
10th May 20134:35 pmRNSPrice Monitoring Extension
17th Apr 20133:33 pmRNSDirectors' Shareholdings
28th Mar 201312:06 pmRNSDirectorate Change
18th Mar 20134:35 pmRNSPrice Monitoring Extension
15th Mar 20134:35 pmRNSPrice Monitoring Extension
8th Mar 20139:00 amRNSInterim Management Statement
19th Dec 20129:00 amRNSHalf Yearly Report
14th Nov 20123:38 pmRNSAppointment of Directors
17th Oct 20125:38 pmRNSDirector/PDMR Shareholding
11th Oct 20122:31 pmRNSResult of AGM
11th Sep 20129:00 amRNSInterim Management Statement
7th Aug 201211:42 amRNSDirector's Report and Accounts
30th Jul 20122:43 pmRNSDirectors Shareholdings
27th Jul 20129:00 amRNSFinal Results
2nd Apr 20124:40 pmRNSSecond Price Monitoring Extn
2nd Apr 20124:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.